Registry of Diabetes Patients in a Large Health Maintenance Organization in Israel

Computerized Registry of Diabetes Patients in a Large Health Maintenance Organization in Israel

Status

Enrolling by invitation

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01779115

Enrollment

126000

Registered

2013-01-30

Start date

1998-01-31

Completion date

Unknown

Last updated

2013-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 Diabetes, Type 2 Diabetes

Keywords

Registry,Diabetes,Health Maintenance Organization

Brief summary

A computerized registry of diabetes patients in a large health maintenance organization in Israel. The registry is aimed to be used by health professionals to identify diabetes patients and to follow the courses of their illnesses and risk factors.

Detailed description

The registry was initiated in 1998 by Maccabi Healthcare services, which is the second largest publicly funded HMO in Israel,serving 24% of the total population with a nationwide distribution. The registry uses advanced information technology that integrates personal computerized community and hospital records, data from laboratory tests, dispensed medications, physiological signals, radiological images, and reports from investigations and procedures.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

Diabetic patient was defined according to the criteria suggested by American Diabetes Association - symptoms diagnosed as diabetes and fasting plasma glucose \>125 mg/dl (7.0 lmol/l) or casual (namely, any time of day without regard to time since last meal) plasma glucose concentration P200 mg/dl. In order to reach maximal validity, we also included any patient who answered to one of the following: (1) purchased at least two hypoglycemic medications or single insulin dose during 6 months. (2) Had HbA1c result of at least 7.25%. HbA1c of 6.5% was used as entry criterion to registry only when the patient was diagnosed as diabetic.

Design outcomes

Primary

Measure	Time frame
Prevalence rates of Diabetes	Up to 100 years

Secondary

Measure	Time frame
Rates of performance of eye examinations,blood and urine tests	up to 100 years
Number and types of Drugs purchased	100 years
Number of visits to physician offices	up to 100 years

Countries

Israel

Outcome results